Properties | Information | |
---|---|---|
PhytoCAT-ID | PhytoCAT-122 | |
Phytochemical name or plant extracts | Carpesium abrotanoides extract | |
PMID | 31750963 | |
Literature evidence | These findings indicate that PCA is a promising agent with practical applications in the development of functional food containing Carpesium abrotanoides L. root extracts. | |
IUPAC name | NA | |
Phytochemicals’ class or type of plant extracts | Petroleum ether extract | |
Source of phytochemicals or plant Extracts | Carpesium abrotanoides | |
Geographical availability | Afghanistan, Albania, Altay, Austria, Belgium, Bulgaria, China North-Central, China South-Central, China Southeast, Czechoslovakia, East Himalaya, Georgia, Germany, Greece, Hainan, Hungary, Iran, Iraq, Italy, Japan, Kazakhstan, Korea, Nepal, Netherlands, North Caucasus, Pakistan, Poland, Romania, Switzerland, Taiwan, Tibet, Transcaucasus, Turkey, Turkey-in-Europe, West Himalaya, Xinjiang, Yugoslavia | |
Plant parts | Root | |
Other cancers | Breast cancer | |
Target gene or protein | PKM2 | |
Gene or Protein evidence | Moreover, PCA downregulated the expression of pyruvate kinase M2 and altered its cellular translocation. | |
Target pathways | NA | |
IC50 | NA | |
Potency | We also demonstrated PCA is an inhibitor of the PKM2/hypoxia-inducible factor-1α axis, indicating that PCA is potentially useful as an anti-breast cancer agent. | |
Cell line/ mice model | MCF-7, MDA-MB-231 | |
Additional information | These findings indicate that PCA is a promising agent with practical applications in the development of functional food containing Carpesium abrotanoides L. root extracts. | |
PubChem ID | NA | |
Additional PMIDs | NA | |
Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:189330-1 | |
Safety | NA |